Studies on circadian periodicity of urinary corticoids in carcinoma of the breast

In Vivo

Volumn 12, Issue 1, 1998, Pages 69-73

  Singh, R ^a   Singh, R K ^a   Mahdi, A A ^a   Misra, S ^a   Rai, S P ^a   Singh, D ^b   Cornelissen G ^c   Halberg, F ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b BRD MEDICAL COLLEGE   (India)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breasr cancer; Circadian; Mastectomy; Tropical conditions; Urinary corticoids

Indexed keywords

17 OXOSTEROID; CORTICOSTEROID; CREATININE;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HUMAN; MASTECTOMY; STEROID URINE LEVEL;

EID: 0031966653     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Allen BJ, Hayward JL and Merivale WHH: The excretion of 17-ketosteroid in urine of patients with generalized carcinomatosis secondary to carcinoma of the breast. Lancet 1: 496-499, 1957.
2. Bulbrook RD, Hayward JL, Spices CC and Thomal BS: Abnormal excretion of urinary steroid by woman with early breast cancer. Lancet 2: 1238-1240, 1962.
3. Beck JC, Blair AJ, Griffiths MM, Rosenfeld NW and McGarry EE: Corticosteroid metabolism in breast cancer. In- VI Canadian Cancer Conference (Begg RW, ed). Oxford, Pergamon Press, 1966, p. 3.
4. Singh RK and Udupa KN: Observations on urinary 17-ketosteroids in breast cancer patients. J Postgrad Med 23: 172-174, 1977.
5. Singh RK, Singh S and Razdan JL: Circadian periodicity of plasma 17-hydroxycorticosteroids in advanced breast cancer. Progress in Clinical and Biological Research 227B: 335-342, 1987.
6. Singh JK, Mahdi AA, Singh D, Rai SP and Cornelissen G: Studies on circadian periodicity of plasma 17-hydroxycorticosteroids (17- OHCS) in carcinoma of breast. In vivo 9: 279-282, 1995.
7. Schwartz SI: In: Principles of Surgery, 3rd ed., New York/St. Louis, McGraw-Hill, Vol. 1, 1979, pp. 572-573.
8. Appleby JI, Gibson G, Norymbersky JK and Stubbs RD: Indirect analysis of corticosteroids. I: The determination of 17- hydroxycorticosteroids. Biochem J 60: 453-455, 1955.
9. King EJ and Wootton IDP: In: Microanalysis in Medical Biochemistry, 4th ed., London: JA Churchill, 1964, pp. 177-178.
10. Wootton IDP: Organic constituents. In: Microanalysis In Medical Biochemistry, 5th ed., London: JA Churchill, 1974, pp. 79-80.
11. Halberg F, Johnson EA, Nelson W, Runge W, Sothern R: Autorhythmometry - procedures for physiologic self- measurements and their analysis. Physiol Tchr 1: 1-11, 1972.
12. Halberg F and Blngham C: The scope and promise of chronobiology and biostatistics: interpenetrating, inseparable disciplines. Proc. Biopharmaceutical Section, Am. Statistical Assn., Chicago, Illinois, August 15-18, 1986, pp. 11-32, 1987.
13. Halberg F, Cornelissen G, Carandente F: Chronobiology leads toward preventive health care for all: cost reduction with quality improvement. A challenge to education and technology via chronobiology. Chronobiologia 18: 187-193, 1991.
14. Cornelissen G, Halberg F: Broadly pertinent chronobiology methods quantify phosphate dynamics (chronome) in blood and urine. Clin. Chem 38: 329-333, 1992.
15. Macey S.L. (ed.). Encyclopedia of Time. Garland Publishing, New York, 1994, 699 pp.
16. Darwin C: The Expression of Emotion in Man and Animals. Chicago: Univ. of Chicago, 1965, 372 pp.
17. Halberg F, Sonkowsky R, Delmore P, Spector NH, Raab F, Schaffer E and Cornelissen G: Tensions of everyday life: benetensive,' transtensive or maletensive chronome-dependent outcomes of chrononeuroimmunomodulation. In: Cornelissen G, Halberg E, Bakken E, Delmore P, Halberg F (eds): Toward phase zero preclinical and clinical trials: chronobiologic designs and illustrative applications. University of Mlnnesota Medtronic Chronobiology Seminar Series, #6, September 1992, pp. 83-137.
18. Halberg E, Cornellssen G, Bakken E and Halberg F. Chrononeuroimmunomodulation (chrono-NIM): lead-lag cross-correlations of mental state and tumor burden. Chronobiologia 21: 144-145, 1994.
19. Halberg F, Cornelissen G. Halpin C, Burchell H, Watanabe Y, Kumagai Y, Otsuka K, Zaslavskaya R: Fleeting "monitor-", "conflict-" or "grief-associated" blood pressure disorders: MESOR-hypertension and circadian hyperamplitude tension (CHAT). EuroRehab 6: 225-240, 1996.
20. Pavlov IP: Lektsii o rabote bol'shikh polusharii golovnogo mozga (Lectures on the Activity of Cerebral Hemispheres). Moscow: Acad. Nauk SSSR. 1947.
21. Petrova MK: O role funktsional'no oslablennol kory golovnogo mozga v vozniknovenii raz]ichnykh patologlcheskikh protsessov v organizme (On the Role of a Functionally Weak Cerebral Cortex In the Development of Various Pathological States of the Body). Moscow, 1946.
22. Fedorov B.M. Stress: cardiological aspects. Human Physiology 23: 205-213, 1997. [Translated from Fizlologlya Cheloveka 23: 89099, 1997.]
23. Halberg F, Cornélissen G, Shemerovsky KA, Ovsyannikov VI: From Pavlov's recording of time and conditioned reflexes to human nutrition chronophysiology. Invited lecture at symposium on The Physiology of Digestion". Bull Rus Acad Med Sci 50: 47-51, 1996.
24. ie, 1968, pp. 73-126.
25. Selye H: Stress. Explorations 1: 57, 1953.
26. Selye H: What is stress? Metabolism 5: 525-530, 1956.
27. Selye H: Stress without Distress. New York, 1974.
28. Lasarus RS: Psychological stress and coping behavior in laboratory studies and in clinical practice. Proc. Symp. Stress Disease, 1970, p. 178.
29. Levy L. Society, stress, and health: a comprehensive approach. Society, Stress, and Health, 1995, p. 1.
30. Raab F, Schaffer E, Cornelissen G, Halberg F: More on the dentist's role in the prevention of high blood pressure. Chronobiologia 20: 245-250, 1993.
31. Hrushesky WJ: Menstrual cycle timing of breast cancer resection. Recent Results in Cancer Research 140: 27-40, 1996.
32. Timing of breast cancer surgery to be studied. Dialogue (Mayo Clinic), October 1997.